SCHEMBL14873887

SCHEMBL14873887

Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCCN)CC2)n1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 9/20 0.86
▸ SRC P12931 8/20 0.86
▸ LCK P06239 5/20 0.85
▸ PKMYT1 Q99640 3/20 0.85
▸ EPHB6 O15197 2/20 0.85
▸ EGFR P00533 2/20 0.85
▸ FYN P06241 2/20 0.85
▸ CSF1R P07333 2/20 0.85
▸ YES1 P07947 2/20 0.85
▸ LYN P07948 2/20 0.85
▸ RET P07949 2/20 0.85
▸ HCK P08631 2/20 0.85
▸ KIT P10721 2/20 0.85
▸ BCR P11274 2/20 0.85
▸ BRAF P15056 2/20 0.85
▸ EPHA1 P21709 2/20 0.85
▸ EPHA2 P29317 2/20 0.85
▸ EPHA3 P29320 2/20 0.85
▸ EPHA8 P29322 2/20 0.85
▸ EPHB2 P29323 2/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30428989 1.00 ABL1 (0.86) ABL1SRCLCKPKMYT1EPHB6
Hydrochloric Acid SCHEMBL30429930 0.99 ABL1 (0.85) ABL1SRCLCKPKMYT1EPHB6
Hydrochloric Acid SCHEMBL25253500 0.99 ABL1 (0.85) ABL1SRCLCKPKMYT1EPHB6
SCHEMBL15984308 0.95 ABL1 (0.89) ABL1SRCLCKPKMYT1EPHB6
SCHEMBL31501075 0.95 ABL1 (0.89) ABL1SRCLCKPKMYT1EPHB6
SCHEMBL29618215 0.94 ABL1 (0.87) ABL1SRCLCKPKMYT1EPHB6
SCHEMBL28935340 0.94 ABL1 (0.87) ABL1SRCLCKPKMYT1EPHB6
SCHEMBL15984317 0.93 ABL1 (0.86) ABL1SRCLCKPKMYT1EPHB6
SCHEMBL25207528 0.93 ABL1 (0.91) ABL1SRCLCKPKMYT1EPHB6
SCHEMBL30429951 0.93 ABL1 (0.91) ABL1SRCLCKPKMYT1EPHB6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250122185-A1 COMPOSITIONS AND METHODS COMPRISING SUBSTITUTED N-(2-CHLORO-6-METHYLPHENYL)-2-((6-(6-MEMBERED HETEROCYCLOALKYL)-2-METHYLPYRIMIDIN-4-YL)AMINO)THIAZOLE-5-CARBOXAMIDE ANALOGUES ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. 2025-04-17 — — US disclosed
WO-2023096995-A1 COMPOSITIONS AND METHODS COMPRISING SUBSTITUTED N-(2-CHLORO-6-METHYLPHENYL)-2-((6-(6-MEMBERED HETEROCYCLOALKYL)-2-METHYLPYRIMIDIN-4-YL)AMINO)THIAZOLE-5-CARBOXAMIDE ANALOGUES ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) 2023-06-01 — — WO disclosed
WO-2023096995-A1 COMPOSITIONS AND METHODS COMPRISING SUBSTITUTED N-(2-CHLORO-6-METHYLPHENYL)-2-((6-(6-MEMBERED HETEROCYCLOALKYL)-2-METHYLPYRIMIDIN-4-YL)AMINO)THIAZOLE-5-CARBOXAMIDE ANALOGUES ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) 2023-06-01 — — WO disclosed
US-20140243239-A1 MULTIPLEXED KINASE INHIBITOR BEADS AND USES THEREOF NIH-DEITR 2014-08-28 — — US disclosed
US-20140243239-A1 MULTIPLEXED KINASE INHIBITOR BEADS AND USES THEREOF NIH-DEITR 2014-08-28 — — US disclosed
WO-2013055780-A1 MULTIPLEXED KINASE INHIBITOR BEADS AND USES THEREOF THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2013-04-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122185-A1 COMPOSITIONS AND METHODS COMPRISING SUBSTITUTED N-(2-CHLORO-6-METHYLPHENYL)-2-((6-(6-MEMBERED HETEROCYCLOALKYL)-2-METHYLPYRIMIDIN-4-YL)AMINO)THIAZOLE-5-CARBOXAMIDE ANALOGUES LCK, SRC, MARCKS ABL1 69/4885SRC 2/4885LCK 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback